期刊文献+

18F-FDG PET/CT在非小细胞肺癌放射治疗中应用的研究进展 被引量:5

Research Progress of F-FDG PET/CT in Radiotherapy of Non-small Cell Lung Cancer
在线阅读 下载PDF
导出
摘要 非小细胞肺癌(Non-Small Cell Lung Cancer,NSCLC)是肺癌的主要类型之一,发病率呈逐年上升趋势,大部分患者确诊时已经无法行手术治疗。放射治疗是NSCLC患者的主要治疗方式之一,如何提高放射治疗的精准性是临床医生一直研究的问题。本文基于相关文献对18F-氟代脱氧葡萄糖正电子发射断层/X射线计算机体层摄影成像系统应用于NSCLC放射治疗的各个环节,可明显提高NSCLC诊断准确率、靶区勾画的精准性进行综述,为患者的临床疗效和预后提供参考。 Non-small cell lung cancer(NSCLC)is one of the main types of lung cancer.The incidence rate is increasing,most patients cannot be treated by surgery when they were diagnosed.Radiotherapy is one of the main treatment methods for NSCLC patients.How to improve the accuracy of radiotherapy had been a problem that clinicians have been studying.In this paper,based on relevant literature,18F-fluoro deoxy glucose positron emission tomography is applied to all aspects of NSCLC radiotherapy,which can significantly improve the accuracy of NSCLC diagnosis and the accuracy of target area delineation a comprehensive review to provide a reference for the clinical efficacy and prognosis of patients.
作者 张实来 蒲维维 韦红娇 肖国有 ZHANG Shilai;PU Weiwei;WEI Hongjiao;XIAO Guoyou(Department of Nuclear Medicine,Guangxi Radiology and Clinical Medicine Research Center,Guangxi Key Clinical Specialty(Medical Imaging),Superiority Cultivation Discipline(Medical Imaging),Guangxi Medical University Affiliated Tumor Hospital,Nanning Guangxi 530021,China)
出处 《中国医疗设备》 2020年第9期35-38,59,共5页 China Medical Devices
基金 国家自然基金地区科学基金项目(81760533) 广西重点研发计划(桂科AB19110015) 广西医疗卫生适宜技术开发与推广应用项目(S201633) 广西壮族自治区卫生健康委员会课题(Z20190559,Z20190595,Z20190632,Z20200403,Z20200445,Z20200545) 广西医科大学青年基金课题(GXMUYSF201819)。
关键词 非小细胞肺癌 18F-氟代脱氧葡萄糖 正电子发射断层/X射线计算机体层摄影成像系统 放射治疗 non-small cell lung cancer 18F-fluoro deoxy glucose positron emission tomography-computed tomography radiotherapy
  • 相关文献

参考文献9

二级参考文献77

  • 1俞建华,王荣福.正电子发射断层代谢显像标准摄取值及定量分析的问题与对策[J].中国医学影像技术,2005,21(5):791-794. 被引量:12
  • 2张建华,王荣福.符合探测正电子双时相显像临床应用的研究进展[J].北京医学,2005,27(7):433-438. 被引量:6
  • 3Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2- deoxy-glucose-positron emission tomography scan in non-small- cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group[J]. J Clin Oncol, 1999,17(10):3201-3206.
  • 4Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [^18F]-fluorodeoxyglueose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group[J]. Eur J Cancer, 1999,35(13):1773-1782.
  • 5Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer Inst, 2000,92(3):205-216.
  • 6Mountain CF. Revisions in the international system for staging lung cancer[J]. Chest,1997, 111(6):1710-1717.
  • 7Wong CY, Schmidt J, Bong JS, et al. Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F- 18 FDG PET-CT imaging[J]. Radiat Oncol,2007,2:18.
  • 8Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglueose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project [J]. J Thorac Oncol,2008,3 ( 1 ):6-12.
  • 9Ichiya Y, Kuwabara Y, Sasaki M, et al. A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma[J]. Ann Nucl Med, 1996,10(2): 193-200.
  • 10Dooms C, Verbeken E, Stroobants S, et al. Prognostic stratification of stage ⅢA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometricpathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography[J]. J Clin Oncol,2008,26(7): 1128-1134.

共引文献67

同被引文献64

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部